Bioshares Etf Valuation

BBP -  USA Etf  

USD 50.79  0.14  0.28%

What is the intrinsic value of Bioshares stock? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Bioshares Biotech, is its stock price multiplied by the total number of shares outstanding, calculating Bioshares Biotech's enterprise value requires a different approach. It uses Bioshares Biotech's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Bioshares Biotech shows a prevailing Real Value of $50.86 per share. The current price of the entity is $50.79. At this time, the entity appears to be fairly valued. Our model approximates the value of Bioshares Biotech from analyzing the entity fundamentals such as Price to Sales of 5.60 X, price to earning of 18.03 X, and Three Year Return of 6.73 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Bioshares Valuation 

 
Refresh
Bioshares Biotech Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Bioshares Biotech's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Fairly Valued
Today
50.79
24th of October 2021
Share
Please note that Bioshares Biotech's price fluctuation is very steady at this time. Calculation of the real value of Bioshares Biotech is based on 3 months time horizon. Increasing Bioshares Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bioshares Biotech Products is useful when determining the fair value of the Bioshares etf, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bioshares Biotech. Since Bioshares Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioshares Etf. However, Bioshares Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
50.86
Real Value
52.14
Upside
Estimating the potential upside or downside of Bioshares Biotech Products helps investors to forecast how Bioshares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioshares Biotech more accurately as focusing exclusively on Bioshares Biotech's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
49.5150.7952.07
Details

Bioshares Biotech Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Bioshares Biotech's current stock value. Our valuation model uses many indicators to compare Bioshares Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioshares Biotech competition to find correlations between indicators driving Bioshares Biotech's intrinsic value. More Info.
Bioshares Biotech Products is second largest ETF in one year return as compared to similar ETFs. It is second largest ETF in three year return as compared to similar ETFs reporting about  0.54  of Three Year Return per One Year Return. The ratio of One Year Return to Three Year Return for Bioshares Biotech Products is roughly  1.86 

About Bioshares Biotech Valuation

The equity valuation mechanism determines the current worth of Bioshares Biotech Products on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bioshares Biotech Products. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of Bioshares Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Bioshares Biotech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bioshares Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioshares Biotech. We calculate exposure to Bioshares Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bioshares Biotech's related companies.
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Bioshares Biotech is traded on NYSEArca Exchange in the United States.
Continue to Trending Equities. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.